# SELUTION 4 De Novo Small Vessel IDE Trial

Study · id `cardio:ct-nct05946629` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05946629](<https://clinicaltrials.gov/study/NCT05946629>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05946629

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 960 participants.

## Technical summary

Registry record NCT05946629. Randomized; double masking; primary purpose treatment. Start 2023-10-20 (actual); primary completion 2027-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 960 participants (planned count; ClinicalTrials.gov record NCT05946629, source copy `cardio:ctgov-nct05946629-2026-09-24`, retrieved 2026-10-26)
- Started: 2023-10-20 (actual) (ClinicalTrials.gov record NCT05946629, source copy `cardio:ctgov-nct05946629-2026-09-24`, retrieved 2026-10-26)
- Primary completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT05946629, source copy `cardio:ctgov-nct05946629-2026-09-24`, retrieved 2026-10-26)
- Completion: 2031-09 (anticipated) (ClinicalTrials.gov record NCT05946629, source copy `cardio:ctgov-nct05946629-2026-09-24`, retrieved 2026-10-26)
- Countries: United States; Belgium; Germany (ClinicalTrials.gov record NCT05946629, source copy `cardio:ctgov-nct05946629-2026-09-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05946629-2026-09-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: SELUTION 4 De Novo Small Vessel IDE Trial
- Condition: Coronary Artery Disease
- Intervention (Device): PCI with SELUTION SLR DCB
- Intervention (Device): PCI with FDA approved "-limus" DES
- Lead sponsor: M.A. Med Alliance S.A.
- Lead sponsor class: INDUSTRY
- Collaborator: NAMSA
- Collaborator class: OTHER
- Collaborator: Cordis US Corp.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: M.A. Med Alliance S.A. (`cardio:org-m-a-med-alliance-s-a`)
- Registry lists this organization as a collaborator: Cordis US Corp. (`cardio:org-cordis-us-corp`)

## Provenance

Content hash: a270c86d69d83e93438ee04d4f7ad08b8042a77499fe38b57945a09ef41a0a29
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
